Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/07/2002US20020164606 Detecting polymorphisms in nucleotide sequence samples; obtain nucleotide sequence sample, incubate with primer, amplify, recover nucleotide sequences and analyze polymorphisms
11/07/2002US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002US20020164601 Enzymatic polypeptide for use in the treatment of infections
11/07/2002US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002US20020164596 Proccess for finding oligonuclestide sequences for nucleic acid amplification methods
11/07/2002US20020164595 Sequence specific DNA binding by p53
11/07/2002US20020164591 Enzymatic polypeptide for use in determining biopolymer sequences
11/07/2002US20020164587 Detecting preferential protein associations; obtain cells, transform with vector containg test protein, express vector, detect adjustment in reproter molecule signal
11/07/2002US20020164585 Expression vector for use in the treatment of viral diseases
11/07/2002US20020164583 Targeting viral vectors to specific cells
11/07/2002US20020164582 Nucleotide sequences coding protein for use in the treatment of viral diseases
11/07/2002US20020164580 Combinatorial screening of mixed populations of organisms
11/07/2002US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002US20020164575 Screening library for genes associated with preferential phenotypes; incubate with zinc finger protein, monitor cells for preferential phenotypes
11/07/2002US20020164572 Human immunodeficiency virus (hiv); azt; pfa; drug resistant viral strains; reverse transcriptase inhibitors; lipophilic phosphonoacid/nucleoside conjugates, with exceptional anti-viral activity, for use against drug-resistant hiv strains
11/07/2002US20020164399 Using enzyme mixture
11/07/2002US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
11/07/2002US20020164355 Test to detect antibodies; calibration
11/07/2002US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002US20020164346 Induce, moderate immunology response
11/07/2002US20020164344 Anticancer agents; vaccines
11/07/2002US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002US20020164334 Antibody-induced apoptosis
11/07/2002US20020164333 Adenovirus gene particles; gene therapy
11/07/2002US20020164330 Novel molecules of the tango-77 related protein family and uses thereof
11/07/2002US20020164320 56939, a novel human acyl-CoA thioesterase family member and uses thereof
11/07/2002US20020164315 Polyampholytes for delivering polyions to a cell
11/07/2002US20020164309 Cell culture of nervous system cells
11/07/2002US20020164304 Lung therapy
11/07/2002US20020164303 Administering nucleic acids to muscle tissue
11/07/2002US20020164301 Methods for inhibiting atherosclerotic plaque formation
11/07/2002US20020164300 Interleukin-2 mutein expressed from mammalian cells
11/07/2002US20020162748 Method for surface treatment of gold-plated body and surface-treated product, and process for producing gold-plated body and gold-plated body, and method for immobilization of sulfur-containing molecules
11/07/2002US20020162550 Sugarcane fractioning system
11/07/2002DE19935772C2 Verfahren zur relativen Quantifizierung der Methylierung von Cytosin Basen in DNA-Proben Method for the relative quantification of the methylation of cytosine bases in DNA samples
11/07/2002DE10109897A1 Fakultativ kationische Liposomen und Verwendung dieser Optional cationic liposomes and use of these
11/07/2002CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002CA2453675A1 Genes and proteins for the biosynthesis of lactimidomycin
11/07/2002CA2452099A1 Prenatal diagnosis method on isolated foetal cell of maternal blood
11/07/2002CA2448607A1 Colloidal metal compositions and methods
11/07/2002CA2446408A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002CA2446101A1 Raav-vectored ribozyme compositions and methods for the treatment of retinal diseases
11/07/2002CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002CA2446003A1 Concentration and purification of analytes using electric fields
11/07/2002CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002CA2445945A1 Modified organs and cells for xenotransplantation
11/07/2002CA2445889A1 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
11/07/2002CA2445887A1 Haemophilus influenzae antigens
11/07/2002CA2445884A1 Elucidation of gene function
11/07/2002CA2445827A1 P450 proteins
11/07/2002CA2445819A1 Recombinant expression of hhbv reverse transcriptase (rt)
11/07/2002CA2445596A1 Method for replicating the hepatitis c virus
11/07/2002CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002CA2445587A1 Multichamber device and uses thereof for processing of biological samples
11/07/2002CA2445532A1 Breast cancer-associated genes and uses thereof
11/07/2002CA2445523A1 Composite scaffolds and methods using same for generating complex tissue grafts
11/07/2002CA2445418A1 Phagemid vectors
11/07/2002CA2445410A1 Ovary-specific genes and proteins
11/07/2002CA2445382A1 Method for generating highly active human dendritic cells from monocytes
11/07/2002CA2445349A1 Anti-cd40 monoclonal antibody
11/07/2002CA2445338A1 G-protein coupled receptors
11/07/2002CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002CA2444973A1 Process for producing coenzyme q10
11/07/2002CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002CA2444854A1 Combinatorial libraries of monomer domains
11/07/2002CA2444508A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/07/2002CA2443719A1 Human fibroblast growth factor-related compositions
11/07/2002CA2441789A1 Method and kit for diagnosing gh deficiency
11/07/2002CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002CA2439199A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002CA2415339A1 Genes and proteins for the biosynthesis of polyketides
11/07/2002CA2385144A1 High throughput polymorphism screening
11/06/2002EP1255113A1 Assay for the determination of the hormonal effect of compounds
11/06/2002EP1254962A1 Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins
11/06/2002EP1254961A1 Improvments in gene therapy using compositions comprising a polynucleotide and interleukin-10
11/06/2002EP1254960A1 A process for increasing the flavonoid content of a plant and plants obtainable thereby
11/06/2002EP1254959A2 Method for producing cytosine nucleoside compounds
11/06/2002EP1254958A1 RICE-ORIGIN GIBBERELLIN 3 beta-HYDROXYLASE GENES AND UTILIZATION THEREOF
11/06/2002EP1254957A2 Method for producing target substance by fermentation
11/06/2002EP1254956A2 Novel osteoinductive compositions
11/06/2002EP1254955A1 A method for regulating gene expression
11/06/2002EP1254952A1 Cells capable of differentiating into heart muscle cells
11/06/2002EP1254951A1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
11/06/2002EP1254913A1 Monoclonal antibodies against CK-MB
11/06/2002EP1254702A2 Spotting device for fabricating microarrays of biological samples and spotting pin inserted therein
11/06/2002EP1254663A1 Anti-virus agent
11/06/2002EP1254657A2 Liposomes
11/06/2002EP1254428A1 A biological molecule based computing method based on a blocking principle
11/06/2002EP1254373A2 Method for identifying and/or characterizing a (poly)peptide
11/06/2002EP1254372A2 Binding acceleration techniques for the detection of analytes
11/06/2002EP1254370A1 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
11/06/2002EP1254369A2 Cells expressing zinc finger protein for drug discovery
11/06/2002EP1254273A2 Process for the enumeration and identification of microorganisms
11/06/2002EP1254271A2 Methods for the storage and synthesis of nucleic acids
11/06/2002EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
1 ... 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 ... 4023